pentobarbital has been researched along with Koch's Disease in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| León-Rivera, I | 1 |
| Mirón-López, G | 1 |
| Molina-Salinas, GM | 1 |
| Herrera-Ruiz, M | 1 |
| Estrada-Soto, S | 1 |
| del Carmen Gutiérrez, M | 1 |
| Alonso-Cortes, D | 1 |
| Navarrete-Vázquez, G | 1 |
| Ríos, MY | 1 |
| Said-Fernández, S | 1 |
1 other study available for pentobarbital and Koch's Disease
| Article | Year |
|---|---|
Tyrianthinic acids from Ipomoea tyrianthina and their antimycobacterial activity, cytotoxicity, and effects on the central nervous system.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antitubercular Agents; Central Nervous System; gamma-Ami | 2008 |